Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

2,642

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

2,642 results for “blindness”

Learn how ShareScore rates datasets ↗
zenodo32/100

Figure 1 in Revealing the cryptic diversity of the widespread and poorly known South American blind snake genus Amerotyphlops (Typhlopidae: Scolecophidia) through integrative taxonomy

Figure 1. Maximum likelihood tree of Typhlopoidea zoomed into the South American radiation of Amerotyphlops. The numbers on the branch represent bootstrap values> 75%. Letter A indicates the species of northern Brazil (Clade A), and letter B indicates species of the Amerotyphlops brongersmianus species complex (Clade B). Colour on branch represents the cryptic species Amerotyphlops sp. 1 (light blue), Amerotyphlops sp. 2 (dark pink), Amerotyphlops sp. 3 (green), and Amerotyphlops sp. 4 (red).

opennotspecifiedNov 2022View details →
zenodo32/100

Figure 4 in Revealing the cryptic diversity of the widespread and poorly known South American blind snake genus Amerotyphlops (Typhlopidae: Scolecophidia) through integrative taxonomy

Figure 4. Holotype of Amerotyphlops caetanoi sp. nov. (MZUSP S-023380). Head in left lateral (A), dorsal (B) and ventral (C) views. TTL = 176 mm. Scale bar equal to 5 mm.

opennotspecifiedNov 2022View details →
zenodo32/100

Figure 11 in Revealing the cryptic diversity of the widespread and poorly known South American blind snake genus Amerotyphlops (Typhlopidae: Scolecophidia) through integrative taxonomy

Figure 11. Holotype of Amerotyphlops montanum sp. nov. (MZUSP 20065). Head in left lateral (A), dorsal (B) and ventral (C) views. TTL = 216 mm. Scale bar equal to 5 mm.

opennotspecifiedNov 2022View details →
zenodo32/100

Figure 12 in Revealing the cryptic diversity of the widespread and poorly known South American blind snake genus Amerotyphlops (Typhlopidae: Scolecophidia) through integrative taxonomy

Figure 12. Holotype of Amerotyphlops martis sp. nov. (MNRJ 18744). Head in left lateral (A), dorsal (B) and ventral (C) views. TTL = 157 mm. Scale bar equal to 5 mm.

opennotspecifiedNov 2022View details →
zenodo32/100

Figure 9 in Revealing the cryptic diversity of the widespread and poorly known South American blind snake genus Amerotyphlops (Typhlopidae: Scolecophidia) through integrative taxonomy

Figure 9. Three-dimensional reconstruction of the anterior region of the left mandible in Amerotyphlops species based on HRXCT data. A, Amerotyphlops caetanoi sp. nov. (MZUSP S-023380); B, Amerotyphlops montanum sp. nov. (MZUSP 20065). Insert shows a lateral profile of the skull of A. brongersmianus presenting in red the position of the detailed region. Scales bars equal to 5 mm. Abbreviations: cb, compound bone; co, coronoid; d, dentary; sp, splenial.

opennotspecifiedNov 2022View details →
zenodo32/100

Safety and immunogenicity of heterologous booster immunization with Ad5-nCoV after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults: a randomized, double-blind, parallel-controlled trial

<p>Data on safety and immunity of heterologous booster (fourth dose) after three-dose priming with inactivated SARS-CoV-2 vaccine are limited in Chinese adults. Here, we evaluate the safety and immunogenicity of immunization with Ad5-nCoV in a randomized, double-blind, parallel-controlled phase 4 clinical trial in Zhejiang, China (NCT05373030). Participants aged 18-80 years (100 participants per group) who have administered three doses of inactivated SARS-CoV-2 vaccine &ge; 6-month earlier were enrolled and randomized at 1:1 into two groups, then administered intramuscular Ad5-nCoV or different inactivated SARS-CoV-2 vaccine (CoronaVac or Covilo) respectively. All observed adverse reactions were predictable and manageable. Ad5-nCoV elicited significantly higher RBD-specific IgG levels, with a GMC of 2924.0 on day 14 post-booster, 7.8-fold that of the inactivated vaccine. Pseudovirus-neutralizing antibodies to Omicron BA.4/5 showed a similar pattern, with GMT of 228.9 in the Ad5-nCoV group and 65.5 in the inactivated vaccine group. The Ad5-nCoV booster-maintained a high antibody levels on day 90, with seroconversion of 71.4%, while the inactivated vaccine group was 5.2%, closed to pre-booster levels. In summary, a fourth Ad5-nCoV vaccination following three-dose inactivated SARS-CoV-2 vaccination is immunogenic, tolerable, and more efficient than inactivated SARS-CoV-2 vaccine. Ad5-nCoV elicits a stronger humoral response against Omicron BA.4/5 and maintains antibody levels for longer than homologous boosting.</p>

opencc-by-4.0May 2023View details →
zenodo32/100

Leukocyte- and Platelet-Rich Fibrin in endoscopic endonasal skull base reconstruction: study protocol for a multicenter prospective, parallel-group, single-blinded randomized controlled non-inferiority trial.

<p>Instruction video on how to prepare Leukocyte- and Platelet-Rich Fibrin for endoscopic endonasal skull base reconstruction reinforcement.&nbsp;</p>

opencc-by-4.0Dec 2022View details →
zenodo32/100

Display and Use of Station Floor Plans on 2D Pin Matrix Displays for Blind and Visually Impaired People.

<p>An open-access repository of train station floor plans primarily covering Germany&#39;s Badden-Wuttermberg and Bavaria districts. The collection includes PNG and PDF formats for accessibility, particularly for individuals with visual impairments. Future expansions aim to include floor plans from additional European train stations.</p>

opencc-by-4.0Aug 2023View details →
ClinicalTrials.gov32/100

A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center C

ClinicalTrials.gov study NCT01965418. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage

ClinicalTrials.gov study NCT01787123. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

TADCLOT- a Double Blind Randomized Controlled Trial

ClinicalTrials.gov study NCT06318481. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.

ClinicalTrials.gov study NCT00637533. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

An Randomized Double Blind Controlled Trial of niPGT-A in Women With RPL

ClinicalTrials.gov study NCT05685147. IPD Sharing: NO. Countries: 1. Publications: 12.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Randomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-malignant Pain

ClinicalTrials.gov study NCT00547885. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effectiveness of Percutaneous Electrolysis in the Treatment of Lateral Epicondylalgia. A Single-Blind Randomized Controlled Trial.

ClinicalTrials.gov study NCT03225404. IPD Sharing: Not stated. Countries: 1. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels

ClinicalTrials.gov study NCT04495608. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Double Blind Trial of DC Polarization in FTD

ClinicalTrials.gov study NCT00117858. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

ClinicalTrials.gov study NCT00686140. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus

ClinicalTrials.gov study NCT00226174. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study

ClinicalTrials.gov study NCT01554995. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.